Submitted by thewallstreetjournal7221 in business
Eye-care company agrees to pay $1.75 billion for Novartis’s dry-eye treatment
Submitted by thewallstreetjournal7221 in business
Eye-care company agrees to pay $1.75 billion for Novartis’s dry-eye treatment